To view digital features for this article, go to Introduction For several decades, N -acetylcysteine (NAC) has been used in clinical practice worldwide in a variety of indications: as a mucolytic, in acetaminophen intoxication, doxorubicin-induced cardiotoxicity and in other cardiovascular, respiratory and psychiatric disorders [1]
mean difference 5.2%, 95% CI 1.908.54, p=0.0023), with a higher proportion of women in the hormone therapy group reaching a total percentage bodyweight change of 20%, 25%, and 30%
Common clinical scenarios where the question arises are for patients who are at increased risk due to family history or genetic risk factors for PDAC, as well as individuals with a history of acute or chronic pancreatitis
The workflow constitutes a mild, peptide-compatible hydroformylation process of allylglycine residues to generate labeled allysine, followed by reductive amination that furnishes radiolabeled lysine residues directly upon cleavage from the solid support
Feb 2016;273(2):285-94